235 related articles for article (PubMed ID: 26242828)
1. Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects.
Azimi F; Mortazavi Y; Alavi S; Khalili M; Ramazani A
Leuk Res; 2015 Oct; 39(10):1048-54. PubMed ID: 26242828
[TBL] [Abstract][Full Text] [Related]
2. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.
Ma X; Zheng J; Jin M; Li W; Gao C; Zhang D; Chen Y; Li X; Xie J
Int J Clin Exp Pathol; 2014; 7(7):4552-6. PubMed ID: 25120852
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474
[TBL] [Abstract][Full Text] [Related]
4. Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population.
Shipkova M; Lorenz K; Oellerich M; Wieland E; von Ahsen N
Clin Chem; 2006 Feb; 52(2):240-7. PubMed ID: 16384889
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.
Atanasova S; Shipkova M; Svinarov D; Mladenova A; Genova M; Wieland E; Oellerich M; von Ahsen N
Ther Drug Monit; 2007 Feb; 29(1):6-10. PubMed ID: 17304144
[TBL] [Abstract][Full Text] [Related]
6. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.
Dorababu P; Nagesh N; Linga VG; Gundeti S; Kutala VK; Reddanna P; Digumarti R
Eur J Clin Pharmacol; 2012 Apr; 68(4):379-87. PubMed ID: 22009189
[TBL] [Abstract][Full Text] [Related]
7. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.
Sumi S; Marinaki AM; Arenas M; Fairbanks L; Shobowale-Bakre M; Rees DC; Thein SL; Ansari A; Sanderson J; De Abreu RA; Simmonds HA; Duley JA
Hum Genet; 2002 Oct; 111(4-5):360-7. PubMed ID: 12384777
[TBL] [Abstract][Full Text] [Related]
9. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
[TBL] [Abstract][Full Text] [Related]
10.
Fan POL; Leung KT; Chan KYY; Leung AWK; Lam GKS; Chow TTW; Cheng FWT; Yuen LYP; Moriyama T; Yang JJ; Li CK
Pediatr Hematol Oncol; 2022 Apr; 39(3):254-266. PubMed ID: 34665987
[TBL] [Abstract][Full Text] [Related]
11. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.
Adam de Beaumais T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
Br J Clin Pharmacol; 2011 Apr; 71(4):575-84. PubMed ID: 21395650
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population.
Maeda T; Sumi S; Ueta A; Ohkubo Y; Ito T; Marinaki AM; Kurono Y; Hasegawa S; Togari H
Mol Genet Metab; 2005 Aug; 85(4):271-9. PubMed ID: 15946879
[TBL] [Abstract][Full Text] [Related]
13. Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy.
Smid A; Karas-Kuzelicki N; Milek M; Jazbec J; Mlinaric-Rascan I
PLoS One; 2014; 9(10):e109551. PubMed ID: 25303517
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.
Farfan MJ; Salas C; Canales C; Silva F; Villarroel M; Kopp K; Torres JP; Santolaya ME; Morales J
BMC Cancer; 2014 Apr; 14():299. PubMed ID: 24774509
[TBL] [Abstract][Full Text] [Related]
15. Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment.
Kouwenberg TW; van den Bosch BJC; Bierau J; Te Loo DMWM; Coenen MJH; Hagleitner MM
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e94-e97. PubMed ID: 31895215
[TBL] [Abstract][Full Text] [Related]
16. The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene.
Arenas M; Duley J; Sumi S; Sanderson J; Marinaki A
Biochim Biophys Acta; 2007 Jan; 1772(1):96-102. PubMed ID: 17113761
[TBL] [Abstract][Full Text] [Related]
17. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects.
Zamzami MA; Duley JA; Price GR; Venter DJ; Yarham JW; Taylor RW; Catley LP; Florin TH; Marinaki AM; Bowling F
J Hematol Oncol; 2013 Mar; 6():24. PubMed ID: 23547827
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
Hawwa AF; Millership JS; Collier PS; Vandenbroeck K; McCarthy A; Dempsey S; Cairns C; Collins J; Rodgers C; McElnay JC
Br J Clin Pharmacol; 2008 Oct; 66(4):517-28. PubMed ID: 18662289
[TBL] [Abstract][Full Text] [Related]
19.
Moradveisi B; Muwakkit S; Zamani F; Ghaderi E; Mohammadi E; Zgheib NK
Front Pharmacol; 2019; 10():916. PubMed ID: 31507415
[No Abstract] [Full Text] [Related]
20. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD
Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
